Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial.

View/ Open
Date
2018Author
Landovitz, Raphael J.
Li, Sue.
Grinsztejn, Beatriz.
Dawood, Halima.
Liu, Albert Y.
Magnus, Manya.
Hosseinipour, Mina C.
Panchia, Ravindre.
Cottle, Leslie.
Chau, Gordon.
Richardson, Paul.
Marzinke, Mark A.
Hendrix, Craig W.
Eshleman, Susan H.
Zhang, Yinfeng.
Tolley, Elizabeth.
Sugarman, Jeremy.
Kofron, Ryan.
Adeyeye, Adeola.
Burns, David.
Rinehart, Alex R.
Margolis, David.
Spreen, William R.
Cohen, Myron S.
McCauley, Marybeth.
Eron, Joseph J.
Metadata
Show full item recordAbstract
Abstract available in pdf.
URI
http://dx.doi.org/10.1371/journal.pmed.1002690https://researchspace.ukzn.ac.za/handle/10413/16641